Monogenic Obesity clinical trials

Explore recruiting monogenic obesity clinical trials.

Recruiting monogenic obesity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Monogenic Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Study of Mibavademab (REGN4461), a Leptin Receptor Agonist, for the Treatment of Monogenic Obesity Due to Biallelic Loss of Function Variants of the LEP Gene

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Monogenic Obesity trials by city

Monogenic Obesity in Toronto Monogenic Obesity in Vancouver Monogenic Obesity in Montreal Monogenic Obesity in Calgary Monogenic Obesity in Edmonton Monogenic Obesity in Ottawa Monogenic Obesity in Winnipeg Monogenic Obesity in Quebec City Monogenic Obesity in Hamilton Monogenic Obesity in Kitchener Monogenic Obesity in London Monogenic Obesity in Halifax Monogenic Obesity in New York Monogenic Obesity in Los Angeles Monogenic Obesity in Chicago Monogenic Obesity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease